Ads
related to: sodium oxalate toxicity causes what cancer in men treatment- About PH1
Discover an FDA-approved treatment
for patients with PH1.
- Dosing & Administration
See dosage and administration info
for an available PH1 treatment.
- Patient Brochure
Help your patients
understand their condition.
- Clinical Data
Review clinical trial data for an
available PH1 treatment.
- Fill Out the Start Form
Fill out the Start Form to get
access to therapy.
- Efficacy & Safety
Read the efficacy & safety profile
of this treatment option for PH1.
- About PH1
Search results
Results From The WOW.Com Content Network
It contains sodium cations Na + and oxalate anions C 2 O 2− 4. It is a white, crystalline, odorless solid, that decomposes above 290 °C. [2] Sodium oxalate can act as a reducing agent, and it may be used as a primary standard for standardizing potassium permanganate (KMnO 4) solutions. The mineral form of sodium oxalate is natroxalate.
The main therapeutic approach to primary hyperoxaluria is still restricted to symptomatic treatment, i.e. kidney transplantation once the disease has already reached mature or terminal stages. However, through genomics and proteomics approaches, efforts are currently being made to elucidate the kinetics of AGXT folding which has a direct ...
After the development of kidney failure patients may get deposits of oxalate in the bones, joints and bone marrow. Severe cases may develop haematological problems such as anaemia and thrombocytopaenia. The deposition of oxalate in the body is sometimes called "oxalosis" to be distinguished from "oxaluria" which refers to oxalate in the urine.
Oxalate (systematic IUPAC name: ethanedioate) is an anion with the chemical formula C 2 O 2− 4. This dianion is colorless. It occurs naturally, including in some foods. It forms a variety of salts, for example sodium oxalate (Na 2 C 2 O 4), and several esters such as dimethyl oxalate ((CH 3) 2 C 2 O 4). It is a conjugate base of oxalic acid.
Kidney toxicity [5] associated with kidney failure; associated with development of cancer, particularly of the urinary tract, known carcinogen [8] [9] Atractylate Atractylis gummifera: Liver damage, [3] nausea, vomiting, epigastric and abdominal pain, diarrhoea, anxiety, headache and convulsions, often followed by coma [10]
Lumasiran is indicated for the treatment of primary hyperoxaluria type 1 (PH1) in adults and children of all ages. [9] [10] PH1 is a rare illness that causes the liver to produce an excessive amount of oxalate. [9] [10] Oxalate is removed by the kidneys and through the urine. [9]
A painting from 1681 depicting a person affected by nausea and vomiting. Cancer and nausea are associated in about fifty percent of people affected by cancer. [1] This may be as a result of the cancer itself, or as an effect of the treatment such as chemotherapy, radiation therapy, or other medication such as opiates used for pain relief.
Oxaliplatin by itself has modest activity against advanced colorectal cancer. [16] When compared with just 5-fluorouracil and folinic acid administered according to the de Gramont regimen, a FOLFOX4 regime produced no significant increase in overall survival, but did produce an improvement in progression-free survival, the primary end-point of the phase III randomized trial.